Johann Sebastian De Bono - Toxicology

Author Information

Dr. Johann Sebastian De Bono is a renowned researcher affiliated with The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, both located in Sutton, UK. His work primarily focuses on cancer research, particularly prostate cancer. Dr. De Bono has made significant contributions to the field through various clinical trials and studies, advancing the understanding and treatment of cancer.

Research Contributions

Dr. Johann Sebastian De Bono has an extensive publication record, with numerous studies conducted in 2022 alone. His research spans multiple aspects of cancer treatment, including the use of abiraterone acetate plus prednisolone for metastatic prostate cancer, artificial intelligence for predicting drug responses in non-small cell lung cancer, and the evaluation of various therapeutic agents like BXCL701 and olaparib. His work has also delved into the genetic aspects of cancer, such as homologous recombination repair gene alterations and the role of non-coding RNAs. Dr. De Bono's studies are often published in high-impact journals, reflecting their significance in the field.

Aliases

Dr. Johann Sebastian De Bono is also known by several aliases, including J S De Bono, Johann S. De Bono, J De Bono, J.s. De Bono, J. S. De Bono, J. De Bono, J Sebastian De Bono, Johan S. De Bono, Johann De Bono, and Johann S De Bono.

Publication and Citation Metrics

Total Citations 62,291
H-Index 113
Total Publications 638

Publications:

DOI: 10.1016/j.annonc.2022.01.018

Year: 2022